Похожие презентации:
Global initiative for chronic obstructive lung disease (GOLD)
1.
GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD):TEACHING SLIDE SET
2020
This slide set is restricted for academic and educational purposes only.
Use of the slide set, or of individual slides, for commercial or promotional
purposes requires approval from GOLD.
© 2020 Global Initiative for Chronic Obstructive Lung Disease
2.
© 2020 Global Initiative for Chronic Obstructive Lung Disease3.
© 2020 Global Initiative for Chronic Obstructive Lung Disease4.
Note: This is a simplified diagram of FEV1 progression over time. In reality, there is tremendous heterogeneity in the rate of decline in FEV 1owing to the complex interactions of genes with environmental exposures and risk factors over an individual’s lifetime
[adapted from Lange et al. NEJM 2015;373:111-22].
© 2020 Global Initiative for Chronic Obstructive Lung Disease
5.
© 2020 Global Initiative for Chronic Obstructive Lung Disease6.
© 2020 Global Initiative for Chronic Obstructive Lung Disease7.
© 2020 Global Initiative for Chronic Obstructive Lung Disease8.
© 2020 Global Initiative for Chronic Obstructive Lung Disease9.
© 2020 Global Initiative for Chronic Obstructive Lung Disease10.
© 2020 Global Initiative for Chronic Obstructive Lung Disease11.
© 2020 Global Initiative for Chronic Obstructive Lung Disease12.
© 2020 Global Initiative for Chronic Obstructive Lung Disease13.
© 2020 Global Initiative for Chronic Obstructive Lung Disease14.
© 2020 Global Initiative for Chronic Obstructive Lung Disease15.
© 2020 Global Initiative for Chronic Obstructive Lung Disease16.
© 2020 Global Initiative for Chronic Obstructive Lung Disease17.
© 2020 Global Initiative for Chronic Obstructive Lung Disease18.
© 2020 Global Initiative for Chronic Obstructive Lung Disease19.
© 2020 Global Initiative for Chronic Obstructive Lung Disease20.
© 2020 Global Initiative for Chronic Obstructive Lung Disease21.
© 2020 Global Initiative for Chronic Obstructive Lung Disease22.
© 2020 Global Initiative for Chronic Obstructive Lung Disease23.
© 2020 Global Initiative for Chronic Obstructive Lung Disease24.
© 2020 Global Initiative for Chronic Obstructive Lung Disease25.
© 2020 Global Initiative for Chronic Obstructive Lung Disease26.
© 2020 Global Initiative for Chronic Obstructive Lung Disease27.
© 2020 Global Initiative for Chronic Obstructive Lung Disease28.
© 2020 Global Initiative for Chronic Obstructive Lung Disease29.
© 2020 Global Initiative for Chronic Obstructive Lung Disease30.
© 2020 Global Initiative for Chronic Obstructive Lung Disease31.
© 2020 Global Initiative for Chronic Obstructive Lung Disease32.
© 2020 Global Initiative for Chronic Obstructive Lung Disease33.
© 2020 Global Initiative for Chronic Obstructive Lung Disease34.
© 2020 Global Initiative for Chronic Obstructive Lung Disease35.
© 2020 Global Initiative for Chronic Obstructive Lung Disease36.
© 2020 Global Initiative for Chronic Obstructive Lung Disease37.
© 2020 Global Initiative for Chronic Obstructive Lung Disease38.
© 2020 Global Initiative for Chronic Obstructive Lung Disease39.
© 2020 Global Initiative for Chronic Obstructive Lung Disease40.
© 2020 Global Initiative for Chronic Obstructive Lung Disease41.
© 2020 Global Initiative for Chronic Obstructive Lung Disease42.
© 2020 Global Initiative for Chronic Obstructive Lung Disease43.
© 2020 Global Initiative for Chronic Obstructive Lung Disease44.
© 2020 Global Initiative for Chronic Obstructive Lung Disease45.
© 2020 Global Initiative for Chronic Obstructive Lung Disease46.
TABLE 4.10 (Part I)© 2020 Global Initiative for Chronic
Obstructive Lung Disease
47.
TABLE 4.10 (Part II)© 2020 Global Initiative for Chronic Obstructive Lung Disease